Preventive vaccination against cervical cancer: Korean society of gynecologic oncology guideline

Kyung Jin Min, Sang Hoon Kwon, Sunghoon Kim, Hyun Jung Kim, Seok Ju Seong, Yong Jung Song, Jin Woo Shin, Keun Ho Lee, Myong Cheol Lim, Hyun Hoon Chung, Woong Ju, Jin-Hwa Hong, Jeong Won Lee, Jae Weon Kim, Duk Soo Bae, Jae Kwan Lee

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

After human papillomavirus (HPV) vaccine guidelines published by Korean Society of Gynecologic Oncology (KSGO) in 2011, new studies have been published, leading to additional data regarding efficacy, safety, number of vaccination rounds, and ideal age of vaccine administration. We searched and reviewed the literatures focused on the efficacy of 2-dose schedule vaccination, the efficacy of 3-dose schedule vaccination in middle-aged women, the ideal age of 3-dose schedule vaccination, the safety of HPV preventive vaccine, and the ability of cross-protection of each HPV preventive vaccine. The KSGO has revised the previous guideline based on the results of the above studies.

Original languageEnglish
Article numbere30
JournalJournal of Gynecologic Oncology
Volume27
Issue number3
DOIs
Publication statusPublished - 2016 May 1

Fingerprint

Papillomavirus Vaccines
Uterine Cervical Neoplasms
Vaccination
Guidelines
Appointments and Schedules
Cross Protection
Safety
Vaccines

Keywords

  • Human papillomavirus vaccine
  • Uterine cervical neoplasms

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynaecology

Cite this

Preventive vaccination against cervical cancer : Korean society of gynecologic oncology guideline. / Min, Kyung Jin; Kwon, Sang Hoon; Kim, Sunghoon; Kim, Hyun Jung; Seong, Seok Ju; Song, Yong Jung; Shin, Jin Woo; Lee, Keun Ho; Lim, Myong Cheol; Chung, Hyun Hoon; Ju, Woong; Hong, Jin-Hwa; Lee, Jeong Won; Kim, Jae Weon; Bae, Duk Soo; Lee, Jae Kwan.

In: Journal of Gynecologic Oncology, Vol. 27, No. 3, e30, 01.05.2016.

Research output: Contribution to journalArticle

Min, KJ, Kwon, SH, Kim, S, Kim, HJ, Seong, SJ, Song, YJ, Shin, JW, Lee, KH, Lim, MC, Chung, HH, Ju, W, Hong, J-H, Lee, JW, Kim, JW, Bae, DS & Lee, JK 2016, 'Preventive vaccination against cervical cancer: Korean society of gynecologic oncology guideline', Journal of Gynecologic Oncology, vol. 27, no. 3, e30. https://doi.org/10.3802/jgo.2016.27.e30
Min, Kyung Jin ; Kwon, Sang Hoon ; Kim, Sunghoon ; Kim, Hyun Jung ; Seong, Seok Ju ; Song, Yong Jung ; Shin, Jin Woo ; Lee, Keun Ho ; Lim, Myong Cheol ; Chung, Hyun Hoon ; Ju, Woong ; Hong, Jin-Hwa ; Lee, Jeong Won ; Kim, Jae Weon ; Bae, Duk Soo ; Lee, Jae Kwan. / Preventive vaccination against cervical cancer : Korean society of gynecologic oncology guideline. In: Journal of Gynecologic Oncology. 2016 ; Vol. 27, No. 3.
@article{5bdea329f9f4468aa8bc394169d91fae,
title = "Preventive vaccination against cervical cancer: Korean society of gynecologic oncology guideline",
abstract = "After human papillomavirus (HPV) vaccine guidelines published by Korean Society of Gynecologic Oncology (KSGO) in 2011, new studies have been published, leading to additional data regarding efficacy, safety, number of vaccination rounds, and ideal age of vaccine administration. We searched and reviewed the literatures focused on the efficacy of 2-dose schedule vaccination, the efficacy of 3-dose schedule vaccination in middle-aged women, the ideal age of 3-dose schedule vaccination, the safety of HPV preventive vaccine, and the ability of cross-protection of each HPV preventive vaccine. The KSGO has revised the previous guideline based on the results of the above studies.",
keywords = "Human papillomavirus vaccine, Uterine cervical neoplasms",
author = "Min, {Kyung Jin} and Kwon, {Sang Hoon} and Sunghoon Kim and Kim, {Hyun Jung} and Seong, {Seok Ju} and Song, {Yong Jung} and Shin, {Jin Woo} and Lee, {Keun Ho} and Lim, {Myong Cheol} and Chung, {Hyun Hoon} and Woong Ju and Jin-Hwa Hong and Lee, {Jeong Won} and Kim, {Jae Weon} and Bae, {Duk Soo} and Lee, {Jae Kwan}",
year = "2016",
month = "5",
day = "1",
doi = "10.3802/jgo.2016.27.e30",
language = "English",
volume = "27",
journal = "Journal of Gynecologic Oncology",
issn = "2005-0380",
publisher = "Korean Society of Gynecologic Oncology and Colposcopy",
number = "3",

}

TY - JOUR

T1 - Preventive vaccination against cervical cancer

T2 - Korean society of gynecologic oncology guideline

AU - Min, Kyung Jin

AU - Kwon, Sang Hoon

AU - Kim, Sunghoon

AU - Kim, Hyun Jung

AU - Seong, Seok Ju

AU - Song, Yong Jung

AU - Shin, Jin Woo

AU - Lee, Keun Ho

AU - Lim, Myong Cheol

AU - Chung, Hyun Hoon

AU - Ju, Woong

AU - Hong, Jin-Hwa

AU - Lee, Jeong Won

AU - Kim, Jae Weon

AU - Bae, Duk Soo

AU - Lee, Jae Kwan

PY - 2016/5/1

Y1 - 2016/5/1

N2 - After human papillomavirus (HPV) vaccine guidelines published by Korean Society of Gynecologic Oncology (KSGO) in 2011, new studies have been published, leading to additional data regarding efficacy, safety, number of vaccination rounds, and ideal age of vaccine administration. We searched and reviewed the literatures focused on the efficacy of 2-dose schedule vaccination, the efficacy of 3-dose schedule vaccination in middle-aged women, the ideal age of 3-dose schedule vaccination, the safety of HPV preventive vaccine, and the ability of cross-protection of each HPV preventive vaccine. The KSGO has revised the previous guideline based on the results of the above studies.

AB - After human papillomavirus (HPV) vaccine guidelines published by Korean Society of Gynecologic Oncology (KSGO) in 2011, new studies have been published, leading to additional data regarding efficacy, safety, number of vaccination rounds, and ideal age of vaccine administration. We searched and reviewed the literatures focused on the efficacy of 2-dose schedule vaccination, the efficacy of 3-dose schedule vaccination in middle-aged women, the ideal age of 3-dose schedule vaccination, the safety of HPV preventive vaccine, and the ability of cross-protection of each HPV preventive vaccine. The KSGO has revised the previous guideline based on the results of the above studies.

KW - Human papillomavirus vaccine

KW - Uterine cervical neoplasms

UR - http://www.scopus.com/inward/record.url?scp=84962343719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962343719&partnerID=8YFLogxK

U2 - 10.3802/jgo.2016.27.e30

DO - 10.3802/jgo.2016.27.e30

M3 - Article

C2 - 27029751

AN - SCOPUS:84962343719

VL - 27

JO - Journal of Gynecologic Oncology

JF - Journal of Gynecologic Oncology

SN - 2005-0380

IS - 3

M1 - e30

ER -